Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.43
-0.0928-0.38%
Volume:144
Turnover:4K
Market Cap:5.62M
PE:- -
High:24.52
Open:24.52
Low:24.43
Close:24.52
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:0.13
T/O Rate:0.06%
Dividend:0.41
Dividend Rate:1.69%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers Health Launches Women's Health Platform in Australia

MT Newswires Live
·
3 hours ago

Hims & Hers Schedules Third-Quarter 2026 Results Release, Conference Call

Reuters
·
3 hours ago

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
3 hours ago

Hims & Hers Health - Announces Launch in Australia

THOMSON REUTERS
·
4 hours ago

Hims & Hers Health - Introduces Hair, Menopause, Perimenopause, and Weight Loss Treatments in Australia

THOMSON REUTERS
·
4 hours ago

Moderately bullish activity in Novo Nordisk with shares down 0.48%

TIPRANKS
·
5 hours ago

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
7 hours ago

Eli Lilly Likely to Post Strong Volume Growth in Q3, RBC Says

MT Newswires Live
·
Yesterday

Eli Lilly Price Target Maintained with a $1500.00/Share by RBC Capital

Dow Jones
·
Yesterday

Scholar Rock Holding (SRRK) Receives a Buy from BMO Capital

TIPRANKS
·
Yesterday

Novo Nordisk price target lowered to $40 from $47 at BMO Capital

TIPRANKS
·
Yesterday

Eli Lilly & Co (LLY) Receives a Buy from Barclays

TIPRANKS
·
Yesterday

Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial

Simply Wall St.
·
Oct 11

Hims Shares Have The Bull Case Changed After Privacy And Billing Lawsuits

Simply Wall St.
·
Oct 10

Moderately bullish activity in Hims and Hers Health with shares up 7.5%

TIPRANKS
·
Oct 10

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
Oct 10

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Oct 10

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Oct 09

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Oct 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 09